நாசி கொரோனா தடுப்பூசி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SEC panel recommends permission for Phase 1 clinical trials of Bharat Biotech s nasal Covid vaccine 
SEC panel recommends permission for Phase 1 clinical trials of Bharat Biotech s nasal Covid vaccine 
Bharat Biotech applied to the DGCI on January 8 seeking permission for conducting phase 1 and phase 2 clinical trials of the intranasal vaccine following which the subject expert committee of the CDSCO on Tuesday deliberated on the application and recommended granting permission for phase 1 trial.
advertisement
UPDATED: January 20, 2021 00:16 IST
Bharat Biotech had earlier this month sent a proposal to DCGI to seek its approval for trials of a nasal vaccine against Covid-19. (Representative image) ....

Krishna Ella , Bharat Biotech , Drugs Controller General , Niti Aayog , Bharat Biotech Nasal Covid Vaccine , Bharat Biotech Nasal Covid 19 Vaccine , Bharat Biotech Nasal Vaccine , Nasal Corona Vaccine , Nasal Coronavirus Vaccine , Nasal Covid Vaccine , கிருஷ்ணா எல்லா , பாரத் பயோடெக் , மருந்துகள் கட்டுப்படுத்தி ஜநரல் , நீதி ஆயோக் , பாரத் பயோடெக் நாசி தடுப்பூசி , நாசி கொரோனா தடுப்பூசி ,